Literature DB >> 7397055

Drug recovery following buccal absorption of propranolol.

J A Henry, K Ohashi, J Wadsworth, P Turner.   

Abstract

1 Buccal absorption of propranolol in two volunteers was followed by repeated rinsing of the mouth with buffer solutions for twelve 2 min periods. Values for absorption, recovery and asymptotic recovery were calculated. 2 Large amounts of propranolol were recoverable from the buccal mucosa; recovery was biexponential and the amount recovered depended on the time allowed for absorption and on the pH of buffers used for recovery. 3 In the case of the drug studied, the buccal absorption test was not an adequate model of passive drug transfer through lipid membranes, and more clearly reflected partitioning into the buccal mucosa. 4 It does not follow from disappearance of drug from the buccal cavity that it has entered the circulation. Unabsorbed drug clearly cannot enter the circulation, but other conclusions about systemic absorption cannot be drawn with certainty from the buccal absorption model. 5 Partitioning back into the saliva after absorption also needs to be taken into account for a true model of systemic absorption of orally administered drugs, and a revised schematic representation of the kinetics of oral drug absorption is presented.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7397055      PMCID: PMC1430026          DOI: 10.1111/j.1365-2125.1980.tb00502.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

Review 1.  ABSORPTION OF DRUGS THROUGH THE ORAL MUCOSA.

Authors:  M GIBALDI; J L KANIG
Journal:  J Oral Ther Pharmacol       Date:  1965-01

2.  A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the beta-blocking drugs atenolol and propranolol.

Authors:  W Schürmann; P Turner
Journal:  J Pharm Pharmacol       Date:  1978-03       Impact factor: 3.765

3.  Buccal absorption of verapamil-evidence for membrane storage [proceedings].

Authors:  B J Davis; A Johnston
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

4.  Kinetics of buccal absorption of amphetamines.

Authors:  R N Beckett AH BOYES; E J Triggs
Journal:  J Pharm Pharmacol       Date:  1968-02       Impact factor: 3.765

5.  Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes.

Authors:  A H Beckett; E J Triggs
Journal:  J Pharm Pharmacol       Date:  1967-12       Impact factor: 3.765

6.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

7.  The buccal absorption characteristics of fomocaine.

Authors:  D J Temple; K R Schesmer
Journal:  Arch Pharm (Weinheim)       Date:  1978-06       Impact factor: 3.751

8.  A model for steroid transport across biological membranes.

Authors:  A H Beckett; M E Pickup
Journal:  J Pharm Pharmacol       Date:  1975-04       Impact factor: 3.765

9.  Absorption kinetics of sublingually administered propranolol.

Authors:  R E Kates
Journal:  J Med       Date:  1977
  9 in total
  7 in total

1.  Bioavailability of propranolol after oral, sublingual, and intranasal administration.

Authors:  G S Duchateau; J Zuidema; F W Merkus
Journal:  Pharm Res       Date:  1986-04       Impact factor: 4.200

2.  Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects.

Authors:  V H Deneer; L Lie-A-Huen; J H Kingma; J H Proost; J C Kelder; J R Brouwers
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

3.  Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine.

Authors:  Jeremy A Bartlett; Kees van der Voort Maarschalk
Journal:  AAPS PharmSciTech       Date:  2012-08-31       Impact factor: 3.246

4.  Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?

Authors:  D B Jack
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

5.  The use of buccal partitioning as a model to examine the effects of aluminium hydroxide gel on the absorption of propranolol.

Authors:  J C McElnay; D J Temple
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

6.  Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.

Authors:  Yanfeng Wang; Zhijun Wang; Zhong Zuo; Brian Tomlinson; Benjamin T K Lee; Michael B Bolger; Moses S S Chow
Journal:  AAPS J       Date:  2013-04-19       Impact factor: 4.009

7.  The effect of variations in urinary pH on the pharmacokinetics of diethylcarbamazine.

Authors:  G Edwards; A M Breckenridge; K K Adjepon-Yamoah; M L Orme; S A Ward
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.